DL

David Licata

President & CEO at 1200 Pharma

California, US

About

David Licata is the Board Member and Co-founder, President and CFO of TORL BioTherapeutics.He previously worked President and CEO at 1200 Pharma. David Licata attended at Stanford University.

Position in the VCSift Database

  • 287 investors hold the President & CEO role in VCSift. David Licata is one of them.
  • 1,751 investors are based in California, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like David

Search Investors